- life sciences/pharma sector
-
Optimizing Clinical Trials
Improve the Efficiency and Effectiveness of Clinical Trials by Reducing Trial Length, Optimizing Patient Recruitment and Lowering Expenditures
Event Date: 2-3 Oct 2008
Location: Sheraton Premiere, Tysons Corner, VA, USA
- key conference speakers
-
Michael Krams Assistance Vice President, Adaptive Clinical Trials, Clinical Development, Wyeth Jim Saunders Vice President, New England Institutional Review Board Ernesto Aycardi World Wide Senior Director, Clinical Research Operations, Merck Geert Kolvenbag Executive Director, Oncology and Infections Development, AstraZeneca Jim Kremidas Global Enrollment Optimization, Eli Lilly
- key conference topics
-
- Patient recruitment and retention methods
- Adaptive clinical trial design
- Performance metrics and benchmarking clinical trials
- Improving dose selection strategies
- Addressing regulatory issues and impact on clinical trials
- key conference features
-
- Explore adaptive clinical trials and uncover best adaptive design methods with Wyeth
- Optimize patient enrolment for global clinical trials with Eli Lilly
- Assess best methods to bridge biomarkers to clinical endpoints with AstraZeneca
- Effectively implement technologies into your clinical trial process with Amgen
- conference focus
-
With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies ne With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Therefore, costs are rapidly increasing due to the growing number and complexity of clinical trials. Clinical organizations can no longer manage trials using uncoordinated, manual, and paper-intensive methods of the past. It is critical they find a better approach to maintain profitability and improve both the efficiency and effectiveness of the clinical trial process. By improving the patient recruitment process, clinical organizations can avoid wasted investments and eliminate costly delays in bringing new drugs to market. By attending this conference attendees will learn cutting-edge strategies to maximize patient recruitment and retention as well as implement best methods to streamline trial management, reduce trial length and lower expenditures.